Guangdong Lifestrong Pharmacy Co., Ltd. (SHE:301111)
China · Delayed Price · Currency is CNY 16.62
-1.10 (-6.21%)
Jul 30, 2026, 3:04 PM CST
SHE:301111 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 310.01 | 314.64 | 278.64 | 292.4 | 283.34 | 349.79 |
Revenue Growth | 11.41% | 12.92% | -4.71% | 3.20% | -19.00% | 2.59% |
Gross Profit Gross Profit Growth | 181.64 | 190.86 | 194.27 | 197.85 | 190.6 | 242.26 |
Operating Income Operating Income Growth | -18.12 | -18.95 | -5.96 | 24.46 | 23.83 | 60.51 |
Net Income Net Income Growth | -4.35 | -4.49 | 4.16 | 33.5 | 33.42 | 57.18 |
Earnings Per Share EPS Growth | -0.03 | -0.03 | 0.03 | 0.21 | 0.21 | 0.48 |
EPS Growth | - | - | -85.71% | 0% | -56.25% | -7.69% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Drug Drug Growth | 271.91 | 271.29 | 289.57 | 272.15 | 336.07 |
Health Consumer Products Health Consumer Products Growth | 16.7 | 1.48 | - | - | - |
Medical Services and Health Management Medical Services and Health Management Growth | 24.5 | 1.6 | - | - | - |
Others Others Growth | 1.52 | 4.27 | 2.82 | - | 0.35 |
Total Total Growth | 314.64 | 278.64 | 292.4 | 283.34 | 349.79 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 201.9 | 250.01 | 322.16 | 345.11 | 451.51 | 553.81 |
Total Debt Total Debt Growth | 45.13 | 45.49 | 72.15 | 13.95 | 0.16 | 1.09 |
Net Cash (Debt) Net Cash Growth | 156.77 | 204.53 | 250.01 | 331.15 | 451.35 | 552.72 |
Net Cash Growth | -35.91% | -18.19% | -24.50% | -26.63% | -18.34% | 311.19% |
Net Cash Per Share Net Cash Per Share Growth | 1.05 | 1.37 | 1.80 | 2.08 | 2.84 | 4.64 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 17.47 | 10.58 | 3.21 | -12.8 | 69.88 | 71.63 |
Capital Expenditures CapEx Growth | -10.92 | -9.78 | -37.9 | -38.61 | -5.54 | -3.09 |
Free Cash Flow Free Cash Flow Growth | 6.55 | 0.8 | -34.69 | -51.41 | 64.34 | 68.54 |
Free Cash Flow Growth | - | - | - | - | -6.13% | 52.97% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 58.59% | 60.66% | 69.72% | 67.66% | 67.27% | 69.26% |
Operating Margin | -5.85% | -6.02% | -2.14% | 8.37% | 8.41% | 17.30% |
Pretax Margin | -3.21% | -3.10% | -0.05% | 12.75% | 12.27% | 19.08% |
Profit Margin | -1.40% | -1.43% | 1.49% | 11.46% | 11.79% | 16.35% |
FCF Margin | 2.11% | 0.26% | -12.45% | -17.58% | 22.71% | 19.59% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.050 | 0.050 | 0.050 | 0.100 | 0.100 | 0.160 |
Dividend Per Share Growth | 0% | 0% | -50.00% | 0% | -37.50% | - |
Dividend Yield | 0.28% | 0.26% | 0.31% | 0.41% | 0.52% | 0.34% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jul '26 Jul 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | - | - | 625.75 | 117.30 | 93.93 | 135.01 |
P/FCF Ratio | 406.17 | 3790.16 | - | - | 48.79 | 112.64 |
PS Ratio | 8.58 | 9.68 | 9.35 | 13.44 | 11.08 | 22.07 |